FutureCeuticals, BioBoron Research Institute form alliance

FutureCeuticals, BioBoron Research Institute form alliance

FutureCeuticals, Inc. announced the formation of a strategic alliance with the BioBoron Research Institute. The mission of the alliance is to advance the study and global commercialization of FruiteX-B(R) Calcium Fructoborate, a patented, nature-identical plant mineral complex available exclusively from FutureCeuticals, Inc.


FutureCeuticals, Inc. announced the formation of a strategic alliance with the BioBoron Research Institute and its renowned director, chemist Dr. Ion Romulus Scorei. The mission of the alliance is to advance the study and global commercialization of FruiteX-B(R) Calcium Fructoborate, a patented, nature-identical plant mineral complex available exclusively from FutureCeuticals, Inc.

Dr. Scorei´s research into Calcium Fructoborate has resulted in nearly a dozen published studies on its unique properties and potential health benefits, most recently on its ability to modulate inflammatory and lipid blood markers in persons exhibiting symptoms of osteoarthritis.

The new collaboration between FutureCeuticals and the BioBoron Research Institute, equipped with state-of-the-art GMP laboratories, creates a potent discovery engine for the proprietary FruiteX-B(R) product. As part of the cooperation, Dr. Scorei and his team will contribute to the chemical and biological differentiation of Calcium Fructoborate from other boron-based compounds.

John M. Hunter, General Manager at FutureCeuticals, stated, "The alliance with the BioBoron Research Institute and Dr. Scorei illustrates our ongoing commitment to enriching our scientific dossier on Calcium Fructoborate, and of providing increased value to our FruiteX-B(R) partners. Dr. Scorei´s expertise will greatly support current business initiatives and our planned push into foreign markets." FutureCeuticals is wrapping up its own clinical study on the effect of FruiteX-B(R) on participant-reported joint discomfort and diminished flexibility and associated inflammatory blood markers.

About FruiteX-B(R) Calcium Fructoborate

FruiteX-B(R), a nutritional supplement breakthrough for joint and bone support, has been shown to beneficially modulate biotargets associated with age-related joint degeneration and inflammation. FruiteX-B(R) is manufactured under US Patent #5,962,049 and issued and pending foreign patents.

About Ion Romulus Scorei, PhD.

Dr. Scorei, professor of Biochemistry at the University of Craiova, founded the BioBoron Research Institute in Romania in 2009. His work on Calcium Fructoborate has earned him gold medal honors from "Inventika International Fair", "International Salon of Innovation, Techniques and New Products", and "International Salon of Inventions and Innovations". In 2010, Dr. Scorei earned the distinction "Science Man of the Year" from the Mihai Eminescu International Academy. He sits on the Editorial Board of Biochemistry and Analytical Biochemistry: Current Research.

About FutureCeuticals, Inc.

FutureCeuticals, Inc. is a vertically integrated functional food ingredient, product development, and bioanalytical research and discovery company with facilities in Illinois, Wisconsin, California, and Europe. http://www.futureceuticals.com.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish